<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2012</study_start_year><condition>Metastatic Colorectal Cancer</condition><condition>Colorectal Neoplasms</condition><disease>Metastatic Colorectal Cancer</disease><disease>Colorectal Neoplasms</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2119071</full_dataset_link><location>United States</location><study_start_month>4</study_start_month><keyword>Previously untreated</keyword><keyword>Oxaliplatin</keyword><keyword>Vitamin D</keyword><keyword>Leucovorin</keyword><keyword>Fluorouracil</keyword><keyword>Bevacizumab</keyword><repository>ECRIN MDR</repository><study_status>Completed</study_status></additional><is_claimable>false</is_claimable><name>Study of Vitamin D in Untreated Metastatic Colorectal Cancer</name><description>This is a prospective, randomized, double-blind phase II trial to evaluate the efficacy and safety of two doses of vitamin D supplementation in combination with standard chemotherapy in participants with previously-untreated metastatic colorectal adenocarcinoma.</description><dates><creation>2012-04-15</creation></dates><accession>2119071</accession><cross_references><ClinicalTrials___gov>NCT01516216</ClinicalTrials___gov></cross_references></HashMap>